Allergy Therapeutics (AGY)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

4.10p
   
  • Change Today:
    -0.15p
  • 52 Week High: 12.10
  • 52 Week Low: 4.10
  • Currency: UK Pounds
  • Shares Issued: 6,332m
  • Volume: 168,369
  • Market Cap: £259.63m
  • RiskGrade: 268
  • Beta: 0.00

Financial Analysis

Select chart: EPS | Dividend | Revenue

Latest Interim/Quarterly

Period Ending Period Revenue (£m) Pre-tax (£m) EPS Dividend
31-Dec-25 Interim 36.28 (19.33) (0.38)p n/a

Key Fundamentals

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
30-Jun-21 84.33 3.66 0.45p 55.6 n/a -60% n/a 0.0%
30-Jun-22 72.77 (12.66) (2.14)p n/a n/a n/a n/a 0.0%
30-Jun-23 59.59 (41.77) (6.43)p n/a n/a n/a n/a 0.0%
30-Jun-24 55.20 (39.17) (1.03)p n/a n/a n/a n/a 0.0%
30-Jun-25 55.04 (39.20) (0.84)p n/a n/a n/a n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

Forecasts

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
30-Jun-26 59.90 (39.00) (0.91)p n/a n/a n/a n/a 0.0%

Copyright © 2026 FactSet Research Systems Inc. All rights reserved.

Price / Earnings Data

5 Yr High 5 Yr Low 5 Yr Avg Curr / Avg
Latest 55.56 n/a 6.23 0

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 6: Forecast figures based on normalised accounts.

 

IFRS Changes - Find Out More

Find out about IFRS and how this affects the financial infomation for all UK companies.

AGY Market Data

Currency UK Pounds
Share Price 4.10p
Change Today -0.15p
% Change -3.53 %
52 Week High 12.10
52 Week Low 4.10
Volume 168,369
Shares Issued 6,332m
Market Cap £259.63m
Beta 0.00
RiskGrade 268

AGY Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
3.80% above the market average3.80% above the market average3.80% above the market average3.80% above the market average3.80% above the market average
2.44% above the sector average2.44% above the sector average2.44% above the sector average2.44% above the sector average2.44% above the sector average
Price Trend
89.34% above the market average89.34% above the market average89.34% above the market average89.34% above the market average89.34% above the market average
81.40% above the sector average81.40% above the sector average81.40% above the sector average81.40% above the sector average81.40% above the sector average
Income Not Available
Growth
33.56% below the market average33.56% below the market average33.56% below the market average33.56% below the market average33.56% below the market average
71.43% below the sector average71.43% below the sector average71.43% below the sector average71.43% below the sector average71.43% below the sector average

What The Brokers Say

Strong Buy 1
Buy 0
Neutral 0
Sell 0
Strong Sell 0
Total 1
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

AGY Dividends

No dividends found

Trades for 27-Oct-2026

Time Volume / Share Price
08:49 49,012 @ 4.10p
08:15 71,569 @ 4.21p
08:14 47,788 @ 4.21p

AGY Key Personnel

CEO Manuel Llobet

Top of Page